Home
/
Surgery Partners, Inc.
/
Financials
/
Quarterly
Surgery Partners, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Surgery Partners, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$417.37M
May 10, 2018
Q3
2017
Sep 30, 2017
$132.26M
Nov 9, 2017
Q2
2017
Jun 30, 2017
$288.35M
Aug 9, 2017
Q1
2017
Mar 31, 2017
$286.18M
May 10, 2017
Q3
2016
Sep 30, 2016
$282.68M
Nov 10, 2016
Q2
2017
Jun 30, 2016
$289.68M
Aug 9, 2017
Q1
2017
Mar 31, 2016
$267.07M
May 10, 2017
Q3
2016
Sep 30, 2015
$239.60M
Nov 10, 2016
Q2
2016
Jun 30, 2015
$232.83M
Aug 10, 2016
Q1
2016
Mar 31, 2015
$224.14M
May 6, 2016
Q3
2015
Sep 30, 2014
$76.30M
Nov 13, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.70M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($2.50M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($37.70M)
May 12, 2025
Q3
2025
Sep 30, 2024
($31.70M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($15.50M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($12.40M)
May 12, 2025
Q3
2024
Sep 30, 2023
($4.90M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
$18.90M
Aug 6, 2024
Q1
2024
Mar 31, 2023
($24.90M)
May 7, 2024
Q3
2023
Sep 30, 2022
($25.00M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($18.40M)
Aug 1, 2023
Q1
2023
Mar 31, 2022
$12.20M
May 2, 2023
Q3
2022
Sep 30, 2021
($22.90M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($26.90M)
Aug 2, 2022
Q1
2022
Mar 31, 2021
($21.00M)
May 3, 2022
Q3
2021
Sep 30, 2020
($61.60M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($32.50M)
Aug 4, 2021
Q1
2021
Mar 31, 2020
($27.50M)
May 5, 2021
Q3
2020
Sep 30, 2019
($15.70M)
Nov 4, 2020
Q2
2020
Jun 30, 2019
($19.80M)
Aug 5, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$105.70M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$111.70M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$61.90M
May 12, 2025
Q3
2025
Sep 30, 2024
$60.90M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$84.80M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$76.00M
May 12, 2025
Q3
2024
Sep 30, 2023
$82.60M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$97.60M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$46.40M
May 7, 2024
Q3
2023
Sep 30, 2022
$74.10M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$76.50M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$100.40M
May 2, 2023
Q3
2022
Sep 30, 2021
$63.60M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$59.50M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$64.30M
May 3, 2022
Q3
2021
Sep 30, 2020
$18.50M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$44.70M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$23.50M
May 5, 2021
Q3
2020
Sep 30, 2019
$59.00M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$55.50M
Aug 5, 2020